Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 12, 2026
TickeronGET DAILY SIGNALS
Security National Financial (SNFCA) Could Reach $10.50 for +17% Upside on Valuation Grounds

Security National Financial (SNFCA) Could Reach $10.50 for +17% Upside on Valuation Grounds

Key Takeaways

  • The $10.50 objective is not a Wall Street consensus; Security National Financial Corporation (SNFCA) has essentially no credible sell-side analyst price targets, so this figure is drawn from public AI-model fair-value discussion.
  • At a recent price of about $8.97, reaching $10.50 would require a gain of roughly 17%, a substantial move for this thinly traded small-cap.
  • There is no meaningful analyst target range to report; major data providers list the consensus target as unavailable or effectively blank.
  • Supporting factors include a low valuation (a trailing P/E around 7), a strong balance sheet, and improving operating-segment performance.
  • Biggest risks are low trading liquidity, earnings volatility tied to investment results, and the stock's small size and limited institutional coverage.
  • Readers can find more about the ticker's Major News, Today's Price Move, Forecast, and Earnings on dedicated pages.
  • Investors seeking broader automated market insight can explore Trending AI Robots.

How the Price Target Was Established

SNFCA is a stock, but it is not one with a meaningful analyst price-target base. Leading aggregators such as MarketBeat report the consensus price target as unavailable, and Benzinga states there is no analysis providing a consensus target. The handful of ratings attached to the name come largely from algorithm-based letter-grade services rather than traditional sell-side research with numeric 12-month targets.

Because no credible aggregate of current analyst targets exists, the $10.50 figure used here comes from public discussion and valuation commentary rather than an analyst consensus. Notably, TipRanks reported that two independent AI models both pointed to a fair value near $10.50, citing a low earnings multiple, a clean balance sheet, and healthy cash generation. This is a valuation-derived reference point, not a guarantee or an official forecast. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Current Market Position and Path Toward the Target

SNFCA recently traded near $8.97, within a 52-week range of roughly $7.33 to $10.23. Reaching $10.50 would represent an approximate 17% upside, a substantial move for a company with a market capitalization around $246 million and average daily volume of only about 30,000 shares.

The path toward that level is best framed through fundamentals rather than momentum. The company operates three segments — life insurance, cemetery and mortuary services, and mortgages — and its recent results reflected steady operating performance despite investment results weighing on reported earnings. Its valuation is notably inexpensive, with a trailing P/E (price-to-earnings) ratio near 7 and a price-to-book multiple below 0.6, which is one reason independent models see upside. However, low liquidity means prices can move sharply on relatively small volumes.

What Could Support a Move Toward the Target

Several verified factors could support a higher price. The company's earnings yield and free-cash-flow yield are elevated relative to its history, and its balance sheet strength — including low leverage — is frequently cited in bullish commentary. Operating segments have been growing through recent quarters, and the insurance and pre-need funeral businesses provide recurring revenue characteristics that can support stable cash generation.

A continued recovery in reported net income, which has been pressured by investment results, could reinforce the value case. If the shares sustain levels above key moving averages and clear resistance, sentiment could improve despite thin coverage. For a value-oriented name trading below book value, even modest multiple expansion would move the price meaningfully toward $10.50.

What Could Prevent the Target From Being Reached

The principal obstacle is the stock's lack of institutional coverage and liquidity. With no active sell-side price targets, there is no catalyst pipeline of target revisions or upgrades to drive re-rating. Earnings volatility is another risk: recent quarters have shown that swings in investment income can overshadow otherwise steady operating results.

Small-cap financials can also remain cheap for long periods if investors stay focused on larger, more liquid names. Technical resistance near the prior highs in the $9.20 to $10.23 area has historically capped rallies, and any deterioration in mortgage demand or insurance underwriting trends could weaken the fundamental case. These risks are real, though not a basis for a definitive directional claim.

Technical Levels and Market Structure

Technical commentary has identified resistance around $9.22 to $9.28, with the 52-week high near $10.23 acting as a broader ceiling. Support has been noted near $8.50. The stock's long-term structure has generally trended higher within a rising channel, but short-term momentum has been mixed, and the shares have periodically retested lower support levels. The $10.00 round-number level sits just below the stated $10.50 objective and could act as a psychological barrier.

Time Horizon and What Investors Should Monitor

The $10.50 figure is best understood as a medium-term valuation reference rather than a dated forecast, since no analyst has attached a formal 12-month horizon. Investors should monitor quarterly earnings and the mix between operating results and investment income, any new analyst initiation or rating, changes in book value, and free-cash-flow generation. Macroeconomic conditions affecting interest rates, mortgage activity, and insurance pricing also matter, as do any signs of improving trading liquidity.

Using AI Tools in My Research

From what I see, tools like Tickeron’s AI Daily Buy/Sell Signals can help surface ideas in names with limited coverage. I find them useful for tracking technical shifts and generating signals based on AI analysis of market conditions, which complements my own review of fundamentals for a stock like this.

Final Assessment

Whether SNFCA can reach $10.50 depends less on analyst conviction — because there is none to speak of — and more on whether its discounted valuation, strong balance sheet, and steady operating segments translate into higher reported earnings and improved investor interest. The roughly 17% move is substantial but not extreme for a low-float stock. The supportive case rests on value and cash generation; the obstacles are thin coverage, earnings volatility, and technical resistance near prior highs. Investors should watch upcoming results and any signs of renewed institutional attention rather than treating the $10.50 figure as a firm forecast.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SNFCA

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


SNFCA in -4.32% downward trend, falling for three consecutive days on November 10, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where SNFCA declined for three days, in 175 of 276 cases, the price declined further within the following month. The odds of a continued downward trend are 63%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SNFCA as a result. In 58 of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 57%.

The Moving Average Convergence Divergence Histogram (MACD) for SNFCA turned negative on November 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 24 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 50%.

The 50-day moving average for SNFCA moved below the 200-day moving average on October 13, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

SNFCA broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The 10-day moving average for SNFCA crossed bullishly above the 50-day moving average on October 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 58%.

Following a +1.32% 3-day Advance, the price is estimated to grow further. Considering data from situations where SNFCA advanced for three days, in 176 of 276 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.

The Aroon Indicator entered an Uptrend today. In 107 of 171 cases where SNFCA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 63%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 28 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.570) is normal, around the industry mean (1.337). P/E Ratio (7.417) is within average values for comparable stocks, (19.773). Projected Growth (PEG Ratio) (0.030) is also within normal values, averaging (0.463). SNFCA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.047). P/S Ratio (0.690) is also within normal values, averaging (1.303).

The Tickeron Seasonality Score of 46 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 52 (best 1 - 100 worst), indicating fairly steady price growth. SNFCA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 64 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock slightly worse than average.

The Tickeron PE Growth Rating for this company is 71 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 78 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are MetLife (NYSE:MET), Prudential Financial (NYSE:PRU), Lincoln National Corp (NYSE:LNC), Genworth Financial (NYSE:GNW).

Industry description

Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.

Market Cap

The average market capitalization across the Life/Health Insurance Industry is 18.5B. The market cap for tickers in the group ranges from 228.36K to 140.68B. CILJF holds the highest valuation in this group at 140.68B. The lowest valued company is GWGHQ at 228.36K.

High and low price notable news

The average weekly price growth across all stocks in the Life/Health Insurance Industry was 1%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was -2%. FG experienced the highest price growth at 12%, while GNW experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the Life/Health Insurance Industry was -57%. For the same stocks of the Industry, the average monthly volume growth was 6% and the average quarterly volume growth was -18%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 39
P/E Growth Rating: 71
Price Growth Rating: 51
SMR Rating: 91
Profit Risk Rating: 60
Seasonality Score: 4 (-100 ... +100)
AI Screener 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a selected lines of life, accident, and health insurance and annuity products

Industry LifeHealthInsurance

Industry
Life Or Health Insurance
Address
433 West Ascension Way
Phone
+1 801 264-1060
Employees
1243
Web
https://www.securitynational.com
Interact to see
Advertisement
BZ dropped sharply, sliding from a $16.72 prior close to $13.48 (-19.38%), with the decline beginning in premarket and deepening into the early regular session. No verified company-specific news or fundamental catalyst was issued; the fall tracked a broad China ADR selloff (the Nasdaq Golden Dragon index slid more than 2%), but that alone is too small to explain a ~20% drop — the stock's Hong Kong listing fell only -2.6%.
Nebius Group N.V. is expected to report third-quarter 2026 results in early November, following a second quarter in which revenue surged 454% year over year. Wall Street consensus tracked by Benzinga points to roughly $937 million in Q3 2026 revenue, up from $146.1 million in the year-ago quarter.
The $1.14 central target is not an analyst consensus; it is the all-cash merger consideration in GoPro, Inc. (GPRO) 's pending deal with Starman Optical, agreed in September 2026. With the stock trading near $0.88, reaching $1.14 would require a move of roughly 29.5%.
AtlasClear Holdings (ATCH) shares fell roughly 25.5% over the last 30 days, declining from $0.1881 on October 2 to $0.1401 on October 30. The pullback extended a longer downtrend that has kept the stock trading well below the $1.00 NYSE American minimum, keeping continued listing-compliance risk in focus.
NVDA fell -2.10% to $216.66 during regular trading, down from a prior close of $221.30. Primary catalyst: hotter-than-expected September CPI data reignited Fed rate-hike fears, raising borrowing costs for AI infrastructure buildouts.
Security National Financial (SNFCA) Could Reach $10.50 for +17% Upside on Valuation Grounds